8-K: Grown Rogue Q1 2026 Revenue Up 28% Amid Expansion

Grown Rogue International reported Q1 2026 revenue of $9.2 million, a 28% year-over-year increase, and raised its full-year 2026 revenue guidance to $34-$37 million.

Summary

• Reported Q1 2026 revenue of $9.2 million, up 28% from $7.2 million in Q1 2025.
• Adjusted EBITDA reached $1.6 million with a 17.1% margin, compared to $1.2 million and 16.6% in the prior year period.
• GAAP net loss was $2.2 million, impacted by $1.5 million in non-cash fair value losses.
• New Jersey operations continue to drive growth, with Phase II expansion expected to double capacity by year-end.
• Construction is ongoing in Minnesota (expected Q1 2027 revenue) and Illinois (expected Q4 2026 operations).
• Launched new in-house vape products in Oregon to improve biomass utilization.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong report, as the company is demonstrating consistent growth and margin discipline while successfully executing on its expansion pipeline.

Positives

• Revenue growth of 28% year-over-year.
• Adjusted EBITDA margin expansion to 17.1% from 16.6%.
• Increased 2026 revenue guidance range to $34-$37 million from $32-$35 million.
• Strong cash position of $13.7 million as of March 31, 2026.
• Successful execution of New Jersey expansion and operational improvements in Michigan.

Negatives

• GAAP net loss of $2.2 million for the quarter.
• Pricing pressure in mature markets like Oregon and Michigan continues to impact profitability.
• Michigan revenue, excluding excise tax impact, declined approximately 4% year-over-year.
• Non-cash fair value losses of $1.5 million negatively impacted the bottom line.

Risks

• Continued pricing declines in mature cannabis markets.
• Execution risks related to construction and regulatory approval timelines in Illinois and Minnesota.
• Potential for short-term, modest reductions in branded product sales percentage during New Jersey capacity ramp-up.
• Cannabis remains illegal under U.S. federal law, creating ongoing regulatory uncertainty.
• Reliance on successful integration of new markets to meet 2027 growth targets.

Future Outlook

Management raised 2026 revenue guidance to $34-$37 million and reiterated 2027 guidance of $50-$58 million in revenue and $14-$18 million in Adjusted EBITDA, driven by expansion in New Jersey, Illinois, and Minnesota.

Management Comments

• New Jersey continues to validate our thesis, with consistent demand for our packaged, branded products and meaningful expansion work underway.
• Mature markets keep us focused on the fundamentals that have always mattered most to Grown Rogue: genetics, passion, quality, consistency, and efficient production.
• Our approach to growth is not based on chasing every license or every market. It is based on disciplined underwriting and building where we believe our capabilities matter most.

Industry Context

StockSavvy.ai notes that Grown Rogue is successfully navigating the 'cannabis winter' by focusing on high-quality indoor flower and disciplined capital allocation, contrasting with competitors who over-expanded during the 2021 boom. The shift to U.S. GAAP reporting signals a move toward institutional-grade financial transparency.

Comparison to Industry Standards

• Revenue growth of 28% outperforms many mid-cap cannabis peers currently struggling with flat or declining sales.
• Adjusted EBITDA margin of 17.1% is competitive for a multi-state operator focusing on craft-quality flower.
• The company's focus on 'fixer-upper' assets in Illinois mirrors successful strategies used by larger operators to minimize capital expenditure.

Corporate Governance

Stakeholder Impact

• Shareholders benefit from increased revenue guidance and clear long-term growth targets.
• Creditors may view the improved Adjusted EBITDA and cash position as a positive indicator of debt service capability.

Next Steps

• Complete Phase II expansion in New Jersey by Q4 2026.
• Commence operations at the Illinois facility later in Q2 2026.
• Continue construction at the Minnesota facility for a Q1 2027 revenue launch.

Key Dates

Recommendation

The company is showing strong operational execution, disciplined capital allocation, and clear growth visibility, making it an attractive prospect for investors seeking exposure to the U.S. cannabis sector.

Keywords

cannabis, Grown Rogue, GRUSF, indoor cultivation, Q1 2026 results, cannabis expansion, New Jersey cannabis